Ask AI
Bill114th CongressFiled Jul 28, 2015Health
H.R. 3250

DXM Abuse Prevention Act of 2015

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to house without amendment (Jul 8, 2016)

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

What just happenedJul 8, 2016

Placed on the Union Calendar, Calendar No. 520.

Who’s behind it

Rep. Johnson, Bill [R-OH-6](R-OH)Sponsor
20 cosponsors10 D10 R
Read on Congress.gov
20cosponsors1committees13actions1related bills8subjects
  1. Jul 8, 2016CalendarsH12410

    Placed on the Union Calendar, Calendar No. 520.

  2. Jul 8, 2016CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 114-672.

    Energy and Commerce Committee
  3. Jul 8, 2016Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 114-672.

    Energy and Commerce Committee
  4. Apr 27, 2016Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  5. Apr 27, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  6. Apr 26, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  7. Apr 25, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  8. Apr 20, 2016Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  9. Apr 20, 2016Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  10. Jul 31, 2015Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  11. Jul 28, 2015IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  12. Jul 28, 2015IntroReferralIntro-H

    Introduced in House

  13. Jul 28, 2015IntroReferral1000

    Introduced in House

Reported to House without amendmentJul 8, 201679

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

Introduced in HouseJul 28, 2015

DXM Abuse Prevention Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Civil monetary penalties that escalate upon repeated violation are imposed.

To possess or receive unfinished DXM, a person must be registered with the Department of Health and Human Services as a producer of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Unfinished DXM may be distributed only to these authorized persons. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

DXM Abuse Prevention Act of 2015 — Informed